These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10892222)

  • 1. Fluoxetine in the treatment of self-mutilating behavior.
    Velazquez L; Ward-Chene L; Loosigian SR
    J Am Acad Child Adolesc Psychiatry; 2000 Jul; 39(7):812-4. PubMed ID: 10892222
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxcarbazepine for self-mutilating bulimic patients.
    Cordás TA; Tavares H; Calderoni DM; Stump GV; Ribeiro RB
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):769-71. PubMed ID: 16893478
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-inflicted eye injury.
    Oren DA; Laor N
    Am J Psychiatry; 1987 Feb; 144(2):248-9. PubMed ID: 3812798
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of kleptomania with serotonin reuptake inhibitors.
    Lepkifker E; Dannon PN; Ziv R; Iancu I; Horesh N; Kotler M
    Clin Neuropharmacol; 1999; 22(1):40-3. PubMed ID: 10047933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obsessive-compulsive symptoms in schizophrenia: remission with anti-obsessive treatment].
    Payá González B; Crespo Facorro B; Sáenz Herrero M; Ayuso Gutiérrez JL
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(3):201-3. PubMed ID: 9717345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychogenic excoriation responding to fluoxetine: a case report.
    Sharma H
    J Indian Med Assoc; 2008 Apr; 106(4):245, 262. PubMed ID: 18828345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attention deficit disorder without hyperactivity, (excessive) masturbation, nail biting/onchophagia, nose picking/rhinotillexomania, finger sucking].
    Ogasawara M; Takeda M
    Ryoikibetsu Shokogun Shirizu; 2003; (40):92-4. PubMed ID: 14626074
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of self-mutilation with olanzapine.
    Garnis-Jones S; Collins S; Rosenthal D
    J Cutan Med Surg; 2000 Jul; 4(3):161-3. PubMed ID: 11003723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More on self mutilation and obsessive compulsive disorder.
    Hollander E; Papp L; Campeas R; DeCaria C; Liebowitz MR
    Can J Psychiatry; 1988 Oct; 33(7):675. PubMed ID: 3058294
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoxetine for OCD after brain injury.
    Stengler-Wenzke K; Müller U
    Am J Psychiatry; 2002 May; 159(5):872. PubMed ID: 11986149
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.
    Warnock JK; Kestenbaum T
    Arch Dermatol; 1992 Dec; 128(12):1623-5. PubMed ID: 1456757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine augmentation of fluoxetine in the treatment of pathological skin picking.
    Christensen RC
    Can J Psychiatry; 2004 Nov; 49(11):788-9. PubMed ID: 15633864
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder.
    Farnam A; Goreishizadeh MA; Farhang S
    Arch Iran Med; 2008 Sep; 11(5):522-5. PubMed ID: 18759519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
    Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
    Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine versus phenelzine in obsessive-compulsive disorder.
    Golwyn DH; Sevlie CP
    Am J Psychiatry; 1999 Jan; 156(1):159-60. PubMed ID: 9892321
    [No Abstract]   [Full Text] [Related]  

  • 16. Obsessive disorder with self-mutilation: a subgroup responsive to pharmacotherapy.
    Primeau F; Fontaine R
    Can J Psychiatry; 1987 Nov; 32(8):699-701. PubMed ID: 3500773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine Augmentation in a Down's Syndrome Adolescent with Treatment- Resistant Obsessive-Compulsive Disorder.
    Pekrul SR; Fitzgerald KD
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):593-5. PubMed ID: 26258664
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of Fluoxetine on Obsessive-Compulsive Behaviors in Children and Adolescents With Autism Spectrum Disorders: A Randomized Clinical Trial.
    Reddihough DS; Marraffa C; Mouti A; O'Sullivan M; Lee KJ; Orsini F; Hazell P; Granich J; Whitehouse AJO; Wray J; Dossetor D; Santosh P; Silove N; Kohn M
    JAMA; 2019 Oct; 322(16):1561-1569. PubMed ID: 31638682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder.
    Corá-Locatelli G; Greenberg BD; Martin J; Murphy DL
    J Clin Psychiatry; 1998 Sep; 59(9):480-1. PubMed ID: 9771822
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluoxetine in Alzheimer's disease with severe obsessive compulsive symptoms and a low density of serotonin transporter sites.
    Marksteiner J; Walch T; Bodner T; Gurka P; Donnemiller E
    Pharmacopsychiatry; 2003 Sep; 36(5):207-9. PubMed ID: 14571357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.